Tether-backed BCI surpasses Neuralink: Ardoino
Among Tether's various investments, Blackrock Neurotech, a brain-computer interface company, is a standout for CEO Paolo Ardoino. In a recent podcast, Ardoino highlighted its potential, suggesting the company is ahead of Elon Musk's Neuralink. Both companies aim to treat neurological disorders through brain implants, but Tether's investment of $200 million in Blackrock Neurotech indicates confidence in its progress. Patients have already achieved significant milestones using its technology. Ardoino envisions creating an open-source 'brain operating system' to ensure technology remains accessible and free from corporate control.
FAQ
❓ What does Blackrock Neurotech specialize in?
Blackrock Neurotech focuses on creating brain-computer interfaces to assist with neurological disorders and enable control of devices through thought.
❓ How does Blackrock Neurotech compare to Neuralink?
According to Paolo Ardoino, Blackrock Neurotech is currently more advanced than Neuralink, having achieved significant patient milestones.
❓ What is Tether's role in Blackrock Neurotech?
Tether is a majority stakeholder in Blackrock Neurotech, investing $200 million to support its innovations in brain-computer interface technology.